key: cord-0966712-34us5wqs
authors: Janowski, Andrew B; Jiang, Hongbing; Fujii, Chika; Owen, Macee C; Bricker, Traci L; Darling, Tamarand L; Harastani, Houda H.; Seehra, Kuljeet; Tahan, Stephen; Jung, Ana; Febles, Binita; Blatter, Joshua A; Handley, Scott A; Parikh, Bijal A; Lulla, Valeria; Boon, Adrianus CM; Wang, David
title: The highly conserved stem-loop II motif is important for the lifecycle of astroviruses but dispensable for SARS-CoV-2
date: 2022-05-02
journal: bioRxiv
DOI: 10.1101/2022.04.30.486882
sha: 580fe2d7caa4aa2b4d8595daa2a5da39fda00f66
doc_id: 966712
cord_uid: 34us5wqs

The stem-loop II motif (s2m) is an RNA element present in viruses from divergent viral families, including astroviruses and coronaviruses, but its functional significance is unknown. We created deletions or substitutions of the s2m in astrovirus VA1 (VA1), classic human astrovirus 1 (HAstV1) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For VA1, recombinant virus could not be rescued upon partial deletion of the s2m or substitutions of G-C base pairs. Compensatory substitutions that restored the G-C base-pair enabled recovery of VA1. For HAstV1, a partial deletion of the s2m resulted in decreased viral titers compared to wild-type virus, and reduced activity in a replicon system. In contrast, deletion or mutation of the SARS-CoV-2 s2m had no effect on the ability to rescue the virus, growth in vitro, or growth in Syrian hamsters. Our study demonstrates the importance of the s2m is virus-dependent.

In 1997, Monceyron et al described a secondary structure present near the 3′ end of classic human astroviruses named the stem-loop II motif (s2m), and a similar element was also identified in avian bronchitis virus, a coronavirus 1 . Subsequently, s2m elements have been detected in members of the Astroviridae, Caliciviridae, Coronaviridae, Picornaviridae, and Reoviridae viral families, all with highly conserved nucleotide sequences of 39-43 nucleotides in length ( Fig. 1A -E) [2] [3] [4] [5] [6] . Currently, the function or necessity of the s2m for the viral lifecycle is poorly understood.

The phylogenetic distribution suggests horizontal acquisition of the s2m at different timepoints, and maintenance of the element suggests that it confers a fitness advantage 2, 3 . The crystal structure of the s2m from severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) demonstrates a tertiary structure that includes a 90° kink in the helix axis that results in additional tertiary interactions 4 . Antisense oligonucleotides to the s2m reduced viral replication for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and classic human astrovirus 1 (HAstV1) replicons 7 . These results suggest that the secondary structure of the s2m is important for virus replication.

Astroviruses are non-enveloped, single-stranded, positive-sense RNA viruses that are approximately 6,000-7,700 nucleotides in length 8, 9 . Astroviruses are associated with infections of the gastrointestinal and nervous systems and harbor additional tissue tropisms 9 . Many astrovirus species encode an s2m near the end of open reading frame 2 (ORF2) 2 . Of the three clades of astroviruses known to infect humans (HAstV, VA, and MLB astroviruses) 8 , members of the HAstV and VA clades contain an s2m, while MLB astroviruses lack an s2m 10 . Previously established culture systems exist for astrovirus VA1 (VA1) and HAstV1 [11] [12] [13] [14] , with published reverse genetics and replicon systems for HAstV1 15, 16 .

Coronaviruses are enveloped, single-stranded, positive-sense RNA viruses that are approximately 30,000 nucleotides in length 17 . Four genera comprise the coronavirus family, with some members of the beta-(sarbecovirus subgenus), gamma-, and delta-genera containing an s2m 3 . Both SARS-CoV-1 and SARS-CoV-2 encode an s2m in the 3′ untranslated region (UTR) 3, 18 .

In contrast, seasonal human coronaviruses (HKU1, 229E, OC43, and NL63) and Middle Eastern respiratory syndrome coronavirus (MERS-CoV) do not contain an s2m 3 . Interestingly, the reference SARS-CoV-2 genome and all subsequent variants of concern encode a unique genetic variant with a uracil at position 32 in the s2m that is distinct from other s2m sequences and is predicted to perturb the secondary structure [19] [20] [21] [22] [23] . Additional genetic variants or deletions of the s2m have been periodically detected from clinical isolates [23] [24] [25] [26] .

We determined the functional significance of the s2m for the viral lifecycle of three viruses, VA1, HAstV1, and SARS-CoV-2 by using reverse genetics to mutagenize the s2m element as well as by studying a clinical isolate of SARS-CoV-2 that has a natural deletion in the s2m region.

VA1 s2m is essential for viral propagation. A reverse genetics system for VA1 was developed using the reference genomic sequence (NC_013060.1; Fig. S1A ). VA1 was consistently rescued with a median viral quantity of 9.4×10 5 focus forming units (FFU)/mL after serial passage ( Table 1, Fig. 2A) . In multi-step growth curves in Caco-2 cells, viral RNA increased >1,000-fold in 24 hours with further increases over time, consistent with a published strain that has been passaged seven times in Caco-2 cells (VA1-C-P7; Fig. S1B ) 11, 12 . We then determined the effect of deletion of the s2m in VA1. Because the predicted stop codon for ORF2 of VA1 is located within the s2m, the last 16 nucleotides of the s2m downstream of the stop codon (named for the nucleotide positions in the multiple sequence alignment: VA1-s2m Δ25-41 ; Table S1 and Fig.   1A ) were deleted. Compared to the wild-type (WT) virus, VA1-s2m Δ25-41 could not be recovered in all 9 attempts (Table 1, Fig. 2A) , suggesting the s2m is critical for VA1.

G-C binding pairs are critical for the function of the VA1 s2m. To further corroborate the importance of the s2m, we created substitutions of specific nucleotides of the s2m (Table S1) .

We first designed a mutant that significantly altered the predicted secondary structure of the s2m by creating a double mutant that contained replacement of cytosines with guanines at positions 12 and 18 (VA1-s2m 12, 18 ; Fig. S2 ). These substitutions affect two guanine-cytosine (G-C) base pairs that are highly conserved in the multiple sequence alignment (Fig. 1A and S2) . Importantly, these substitutions are synonymous and do not alter the amino acid sequence of ORF2. Attempts to rescue and grow VA1-s2m 12, 18 were not successful in all nine attempts (Table 1, Fig. 2A) . We also created substitutions at positions 24 and 33 that form G-C base pairs with positions 12 and 18 (Table S1 ; VA1-s2m 24, 33 ). Both guanines were converted to cytosines, which also alters the predicted secondary structure (Fig. S2) . The substitution at position 24 disrupts the stop codon resulting in addition of 16 amino acids to ORF2 (Table S2) . Like VA1-s2m 12,18 , we could not rescue VA1-s2m 24,33 ( Table 1 , Fig. 2A ). Next, we determined the impact of altering a single G-C base pair by creating point substitutions at position 24 alone (VA1-s2m 24 ) and position 33 alone (VA1-s2m 33 ; Table S1 ). In both mutants, the guanine was converted to a cytosine, resulting in slightly altered s2m secondary structures (Fig. S2) . VA1-s2m 24 results in disruption of the stop codon and adds 16 amino acids to ORF2 while VA1-s2m 33 does not affect the amino acid sequence (Table S2) . No virus could be propagated from either VA1-s2m 24 or VA1-s2m 33 in all 9 rescue attempts, respectively ( Table 1, Fig. 2A) . These results demonstrate that disruption of even a single G-C base pair impacts the biological activity of the VA1 s2m.

Next, we determined if the function of the mutant s2m sequences could be restored by creating complementary substitutions that would reestablish G-C binding pairs but invert them relative to the WT s2m. Using the VA1-s2m 33 mutant as a template, we converted position 12 from a cytosine to guanine (VA1-s2m 12,33 ), which is a synonymous substitution (Table S1-S2).

For VA1-s2m 24 , we altered position 18 by also converting the cytosine to guanine (VA1-s2m 18, 24 ) , also a synonymous substitution (Table S1-S2). This mutant maintains the altered nucleotide at the stop codon resulting in addition of 16 amino acids ( Table S2) . The secondary structures for both VA1-s2m 12,33 and VA1-s2m 18, 24 are predicted to form the WT s2m structure (Fig. S2) . Both reversion mutants yielded viable virus in 7 out of 9 replicates for VA1-s2m 12,33 and 9 out of 9 replicates for VA1-s2m 18, 24 (Table 1, Fig. 2A) . Because VA1-s2m 18, 24 was viable despite alteration of the stop codon, this finding suggests that the extension of ORF2 by 16 amino acids does not by itself compromise the viability of VA1. Finally, we determined if we could recover a mutant in which two G-C base pair sites were inverted compared to WT. We created a quadruple mutant s2m (VA1-s2m 12, 18, 24, 33 ) , that combines the substitutions of VA1-s2m 12,18 and VA1-s2m 24,33 that individually were unrecoverable (Table S1 ). VA1-s2m 12, 18, 24, 33 is predicted to form the same secondary structure as the WT s2m and contains the substitution that disrupts the stop codon ( Fig. S2 and Table S2 ). VA1-s2m 12, 18, 24, 33 was recovered in 8 out of 9 replicates ( Table 1, Fig.   2A ), further confirming the importance of the G-C base pairs in the s2m and that VA1 can tolerate two G-C inversions.

The SARS-CoV-2 s2m encodes uracil at position 32 while essentially all other s2m sequences known to date contain guanine (Fig. 1A) . We further analyzed 295,000 complete SARS-CoV-2 genomes uploaded to the NCBI database from 2020-2021. Of those sequences, there were only 4 genomes with guanine, 5 with cytosine, and 6 with small deletions while all other sequences contained uracil at position 32. In the canonical s2m secondary structure, this position is predicted to form a G-C base pair, and based on our previous results, we hypothesized that VA1 will not tolerate this substitution. To determine if VA1 could tolerate a uracil substitution at this position, we created VA1-s2m 32 (Table S1 and Fig. S2 ). Similar to the other mutant VA1 s2m sequences with disrupted G-C binding pars, VA1-s2m 32 was not rescued in nine attempts (Table 1, Fig. 2A) .

We also noticed in the multiple sequence alignment that position 9 can be variable between viruses (Fig. 1A) , including viruses within the same family. VA1, SARS-CoV-1, and SARS-CoV-2 encode an adenine while classic human astroviruses encode a cytosine. This position is not predicted to form a G-C base pair (Fig. 1B) , but has been identified to form potential long-distance tertiary interactions with nucleotide 30 in the SARS-CoV-1 s2m crystal structure 4 . To evaluate the significance of this position and nucleotide residue, we mutated position 9 in the VA1 s2m by replacing the adenine for a cytosine (VA1-s2m 9 ; Table S1 ). The VA1-s2m 9 mutant could be propagated in 8 out of 9 replicates (Table 1) .

Lastly, we determined if any of the recoverable VA1 mutants had a growth defect relative to WT. For all mutants that were propagated, we confirmed the presence of the expected s2m sequence with the engineered substitutions by Sanger sequencing. We selected one isolate from VA1-s2m-WT, VA1-s2m 9 , VA1-s2m 18 Fig. 2C ). Of the four mutants at 48 hours post-infection (hpi), only VA1-s2m 12, 18, 24, 33 had lower viral RNA compared to WT (2-fold, P= 0.045), but there was no difference in the viral titer for any mutant (all P> 0.8). At 96 hpi, viral RNA and titers were reduced for VA1-s2m 12, 18, 24, 33 (RNA: 3.6-fold, P= 0.0014; virus titer: 4.4-fold, P< 0.001), VA1-s2m 12,33 (RNA: 1.5-fold, P= 0.049; virus titer: 4.9-fold P< 0.001) and VA1-s2m 9 (RNA: 3.3-fold, P< 0.001; virus titer: 6.8-fold, P< 0.001). VA1-s2m 18, 24 had no significant differences in RNA or viral titer (both P> 0.06). These results suggest that some of the recombinant viruses have a growth defect, with VA1-s2m 9 having the greatest reduction at 96 hpi.

The s2m is important for classical human astrovirus 1. To demonstrate the functional significance of the s2m in a different astrovirus, we introduced a partial deletion of the s2m in HAstV1 (Table S1) using a published reverse genetics system 15 . As with the VA1 s2m, the HAstV1 s2m contains a stop codon for ORF2, so we introduced a deletion of 19 nucleotides after the stop codon (HAstV1-s2m Δ25-43 ). In contrast to our results with VA1, recombinant HAstV1 virus containing the deletion could be rescued and had no unexpected mutations identified by Sanger sequencing (Fig. 3A) . We next determined if there was a growth defect of the s2m deletion mutant. In a multistep growth curve in Caco-2 cells, the HAstV1-s2m Δ25-43 mutant had reduced production of virus progeny compared to WT (two-way ANOVA F [1, 4] = 180, P< 0.001), with 2.9to 6-fold decreases occurring at 24 (P= 0.002) , 72 (P= 0.009) and 96 (P= 0.04) hpi (Fig. 3B) .

We further corroborated this result through a HAstV1 based replicon system. In HEK293T cells, the HAstV1-s2m Δ25-43 replicon mutant had activity that was reduced by 80% compared to WT (P= 0.001), while in Huh7.5 cells, the HAstV1-s2m Δ25-43 replicon activity was reduced by 40% (P= 0.002; Fig. 3C-D) . These results demonstrate the importance of the s2m for replication of HAstV1.

The s2m element is dispensable for SARS-CoV-2 in vitro. We next determined the importance of the s2m in the context of a different viral family using SARS-CoV-2. We engineered three recombinant viruses with mutations or deletions in the s2m (Fig. S1C) . First, we deleted nucleotides 2-42 of the SARS-CoV-2 s2m (CoV-2-s2m Δ2-42 ) as the s2m is completely encoded in the 3′ UTR (Table S1) . We also created a mutant that contained four consecutive nucleotide substitutions in the stem region of the s2m (CoV-2-s2m 2-5 ) that is predicted to disrupt the secondary structure as well as a revertant mutant (CoV-2-s2m [2] [3] [4] [5] [39] [40] [41] [42] ) that contained four additional compensatory substitutions that restored the predicted stem region and the SARS-CoV-2 s2m secondary structure (Table S1, Fig. S3 ). All mutant SARS-CoV-2 genomes yielded infectious viral particles that could be propagated in Vero-hTMPRSS2 cells. We confirmed the presence of the engineered mutations and the absence of spontaneous mutations in the SARS-CoV-2 s2m by sequencing. We next tested whether there were any defects in the growth rate of the mutants by conducting multi-step growth curves (Fig. 4A) . There was no significant difference between the WT and mutant viruses at any timepoint in Vero-hTMPRSS2 (African green monkey) cells (two-way ANOVA F[3,20]= 1.02, P= 0.4) or Calu-3 (human) cells (two-way ANOVA F [3, 20] = 0.48, P= 0.7), suggesting that the s2m element is not required for SARS-CoV-2 in vitro (Fig. 4B ). 

Despite the first description of the s2m in 1997, no functional genetic studies on the role of the element in the virus lifecycle have been performed [1] [2] [3] [4] [5] [6] . Here, we demonstrated that the s2m is critical for VA1 and important for HAstV1. In contrast, the deletion or mutation of the s2m in SARS-CoV-2 did not impact growth in vitro or in vivo. These results suggest that the importance and function of the s2m are virus-context dependent.

For VA1, we demonstrated the critical importance of G-C binding pairs in the s2m element, supporting the hypothesized secondary and tertiary structure. The pressure to maintain the structure of the s2m likely places constraints on the nucleotide diversity at each position (Fig. 1A) .

While position 18 can either be guanine or cytosine, position 24 is conserved with a complementary base that maintains a G-C binding pair. We demonstrated that VA1 tolerates both orientations of this G-C base pair without reduction of viral progeny (VA1-s2m-WT and VA1-s2m 18,24 ; Fig. 2C ). Other G-C base pairs including positions 15-29, 16-28, and 17-25 are rigorously conserved across all s2m sequences (Fig. 1A) . One challenge to testing these other G-C base pairs is that most astrovirus s2m elements partially overlap with the coding sequence of ORF2, limiting the mutations that can be introduced without affecting the amino acid sequence.

We did find that VA1 tolerates disruption of the stop codon and the addition of 16 amino acids to the C-terminus of ORF2, as long as the s2m predicted structure was maintained (VA1-s2m 18, 24 and VA1-s2m 12, 18, 24, 33 ). ORF2 encodes the capsid protein, and it is known for HAstV1 and HAstV8 that the protein undergoes proteolytic cleavage [28] [29] [30] [31] . It is possible that VA1 can tolerate the addition of 16 amino acids residues because this additional peptide is part of a larger peptide that is cleaved during the viral lifecycle.

We also identified that nucleotide positions that are not predicted to form G-C base pairs can be modified in the s2m (VA1-s2m 9 ), but this resulted in reduced production of viral progeny (Fig.   2C ). In the multiple-sequence alignment, adenine, cytosine, and guanine are observed to be present at this position (Fig. 1A) . In the crystal structure for the SARS-CoV-1 s2m, position 9 was hypothesized to form a tertiary interaction with nucleotide 30 and may also bind a magnesium ion 4 . In future studies, we can determine if different nucleotide substitutions alter these interactions, providing further insights into what nucleotide substitutions can be tolerated by the s2m.

We corroborated the significance of the s2m for a different astrovirus, HAstV1, and the s2m was important but not critical. These findings highlight that the magnitude of the importance of the s2m is virus-dependent. Unlike VA1, HAstV1 may have greater tolerance to alterations to the s2m as the HAstV1 s2m tolerated replacement with the SARS-CoV-1 and SARS-CoV-2 s2m sequences in a replicon system 7 . Importantly, some astroviruses do not encode an s2m, including viruses of the MLB clade 10 . This observation is consistent with the finding that the s2m is not an integral lifecycle element for all astroviruses.

SARS-CoV-2 contains uracil at position 32 while all other representative s2m-containing viruses encode guanine (Fig. 1A) . This position is predicted to form a G-C binding pair and we experimentally validated the significance of this genetic variant in VA1, as the recombinant VA1-s2m 32 could not be rescued. This result is consistent with the significance of the G-C base pairs in maintaining the s2m structure. It is also consistent with the observation that the s2m element is dispensable in SARS-CoV-2. Other coronaviruses with an s2m, including SARS-CoV-1 and closely related bat coronaviruses RaTG13 (MN996532.2), BANAL-52 (MZ937000.1), and BANAL-236 (MZ937003.2) do not encode uracil at this position 32 . These findings suggest that the uracil genetic variant was a recent evolutionary event. Future identification of more closely related genomes to SARS-CoV-2 will provide further insights into the timing of the emergence of the uracil substitution.

Nonetheless, the presence of the uracil at position 32 in essentially all SARS-CoV-2 genomes (>99.99% on NCBI) raises major questions about the function of the SARS-CoV-2 s2m. Why does SARS-CoV-2 encode an s2m that contains a genetic variant in a position that is predicted to disrupt the secondary structure? Our results demonstrate the SARS-CoV-2 s2m is not critical for the viral lifecycle. There are multiple reports of mutations and deletions of the s2m in SARS-CoV-2 clinical isolates [23] [24] [25] [26] , and the s2m region has, surprisingly, a higher mutational rate compared to other regions of the SARS-CoV-2 genome 23 . These observations, combined with our functional data raise the possibility that SARS-CoV-2 may have evolved an alternate mechanism to substitute for the function of the s2m. Alternatively, the s2m in SARS-CoV-2 may have a unique function but is still dispensable. Given the conservation of the uracil variant for SARS-CoV-2 across clinical isolates, it could provide an unknown fitness advantage.

One possibility for our findings is that the significance of the s2m is cell-line dependent. The s2m was important for both VA1 and HAstV1 in Caco-2 (human) cells, while the SARS-CoV-2 s2m was dispensable in Vero (African green monkey) or Calu-3 (human) cells, confirming the importance of the s2m is not specific to human cells. In addition, we noted different reductions of activity for the HAstV1 replicon system in HEK293T and Huh7.5 cells (Fig 3C-D) . In the future, we can test if the s2m has different magnitudes of importance that dependent on expression levels of specific cellular pathways. In addition, there is currently no in vivo model in which to study either classic or VA-clade astroviruses. Future development of an animal model of astrovirus infection would enable us to determine if the observed in vitro phenotypes translate in vivo.

The mechanism behind the function of the s2m remains unclear. Various hypotheses have been proposed, but a clear function has not been established 2, 4 . Based on the presence of the s2m in viruses of five different viral families, it could act through a shared pro-viral mechanism.

The s2m could be an important element that interacts with the host through s2m-host protein or RNA interactions. Any host pathway affected by the s2m is likely to be highly conserved since the s2m has been identified in viruses that are predicted to infect mammals, birds, and insects 6 . It is also possible that the s2m is a key element for viral RNA-RNA interactions during the viral lifecycle, as suggested by others 33, 34 .

In summary, we have defined differential roles for the s2m element that is virus-context dependent. Further studies will define the mechanistic basis as to why a highly conserved RNA element can lead to different functional roles in the viral lifecycle.

Cell culture conditions. BHK-21, HEK293T and Caco-2 cells were maintained in Dulbecco's Modified Eagle Medium (DMEM) with L-glutamine (Gibco) supplemented with 10% fetal bovine serum (FBS) and 100 units/mL penicillin/streptomycin and incubated at 37°C and 5% CO2.

Huh7.5.1 cells (obtained from Apath, Brooklyn, NY) were maintained in the same media supplemented with non-essential amino acids. Vero cells expressing human TMPRSS2 (Vero-hTMPRSS2) 35 or human ACE2 and human TMPRSS2 (Vero-hACE2-hTMPRSS2, gift from Drs.

Graham and Creanga at NIH) and BSR cells (a clone of BHK-21) were cultured and maintained in DMEM supplemented with 5% FBS and 100 units/mL of penicillin and streptomycin. Vero-hTMPRSS2 and Vero-hACE2-hTMPRSS2 cells were maintained by selection with 5 µg/mL Blasticidin or 10 µg/mL puromycin respectively.

Astrovirus VA1 reverse genetics system. The reference VA1 genome (NC_013060.1) was synthesized using gBlocks (Integrated DNA Technologies) 36 . This genome contains 4 or 5 nucleotide substitutions relative to previously propagated VA1 in cell culture, allowing for differentiation of recombinant virus 11, 12 . During construction of the genome, we identified significant bacterial toxicity of the VA1 sequence that hindered the assembly of the full genome in a plasmid. The toxicity localized to a region of ORF1a of the VA1 genome, so the genome was split into two plasmids (Fig. S1A) . Plasmid p1629 contains a BamHI restriction site, T7 promoter (TAATACGACTCACTATAG) followed by the first 1629 nucleotides of the VA1 genome inserted into the pSMART plasmid (Lucigen). A second plasmid, p5023 contains a BamHI and BlpI restriction site, nucleotides 1610-6586 followed by a poly-A sequence of 18 adenosines, followed by EciI and SbfI restriction digest sites inserted into pUC19. To introduce mutations or deletions in the s2m of the VA1, synthetic DNA encoding for the nucleotides 6080-6586 were commercially synthesized with a poly-A tail added by overlap PCR and cloned into p5023 using unique enzyme restriction sites AgeI and SbfI (Table S1 ).

Due to low yields of p1629, the VA1 insert was amplified by PCR. Wild-type and mutant p5023 plasmids were linearized using BamHI and BlpI. NebBuilder HiFi assembly (New England Biolabs) was used to combine the fragments into the full-length VA1 sequence. The p1629 PCR product was combined with the p5023 fragment at a mass ratio of 1:2.5 using the manufacturer's instructions by incubating the fragments for two hours at 50°C. The DNA was purified using a DNA column (Zymo Research). To cleave the 3′ end and generate a linear template for in vitro transcription, the VA1 DNA sequence was further digested overnight with EciI at 37°C. The DNA was again purified using a DNA column (Zymo Research) and the expected assembled genome DNA length was confirmed by gel electrophoresis. A total of 1 µg of DNA was used for in vitro transcription using mMESSAGE mMACHINE T7 Ultra Transcription kit (Invitrogen) with the 5′ end capped with anti-reverse cap analog (ARCA) and supplemented with GTP (1 µL per 20 µL reaction). After a two-hour incubation at 37°C, Turbo DNase was added and incubated for 15 minutes at 37°C. The RNA was purified using RNeasy (Qiagen) and quantified by Nanodrop Human astrovirus 1 reverse genetics system. Mutant s2m sequences were introduced using site-directed mutagenesis of a previously published plasmid encoding HAstV1 (pAVIC1) 15 and confirmed by sequencing. The resulting plasmids were linearized with XhoI prior to T7 RNA transcription using mMESSAGE mMACHINE T7 Transcription kit (Invitrogen). The pAVIC1derived HAstV1 RNA was electroporated into BSR cells as previously described 16 . For virus passaging and multistep growth curves, the collected supernatant was treated with 10 µg/mL Type IX trypsin (Sigma) for 30 min at 37°C, diluted 5 times with serum-free media, and used for infection of Caco-2 cells. After three hours of incubation, the virus-containing media was replaced with serum free media containing 0.6 µg/mL trypsin, and cells were incubated for 48-72 hours until the appearance of cytopathic effect. After 3 freeze-thaw cycles, viral stocks were titrated using Caco-2 cells on 96-well plates in the absence of trypsin, enabling single-round infection 16 .

The immunofluorescence-based detection with 0.26 µg/mL of 8E7 astrovirus antibody (Santa Cruz Biotechnolgy, sc-53559) was combined with infrared detection readout and automated LI- CoV-2 Wuhan genome (NC_045512.2) was split into 7 fragments (Fig S1C) , named A to G, and each DNA fragment was commercially synthesized (GenScript). A T7 promoter sequence was introduced at the 5′ end of fragment A, and a poly-A sequence of 22 adenosines was introduced at the 3′ end of fragment G. In addition, NotI and SpeI sites were introduced at the 5′ end of fragment A before the T7 promoter and the 3′ end of fragment G after the poly-A sequence, respectively. To ensure seamless assembly of the full virus DNA genome, the 3′ end of fragment A, both ends of fragments B-F and the 5′ end of fragment G were appended by class II restriction enzyme recognition sites (BsmBI and BsaI) (Fig S3C) . Fragments A and C-G were cloned into plasmid pUC57 vector and amplified in E. Coli DH5α strain. The bacteria toxic fragment B was cloned into low copy inducible BAC vector pCCI and amplified through plasmid induction in EPI300. Low copy plasmids were extracted by NucleoBond Xtra Midi kit (MACHEREY-NAGEL) with the other plasmids were extracted by plasmids midi kit (QIAGEN) according to the manufacturers' protocols. To generate mutant s2m sequences, the SARS-CoV-2 s2m sequence in the G fragment was mutated by site-directed mutagenesis (Table S1 ). Mutations and deletions in the s2m element were confirmed by Sanger sequencing. To assemble the full-length SARS-CoV-2 genome, each DNA fragment in plasmid was digested by corresponding restriction enzymes, DNA fragments were recovered by gel purification columns (New England Biolabs), and the seven fragments were ligated at equal molar ratios with 10,000 units of T4 ligase (New England Biolabs) in 100 µL at 16°C overnight. The final ligation product was incubated with proteinase K in the presence of 10% SDS for 30 minutes, extracted twice with equal volume of phenol:chloroform:isoamyl alcohol (25:24:1; ThermoFisher), isopropanol precipitated, air dried and resuspended in RNase/DNase free water. The DNA was analyzed on a 0.6% agarose gel.

Full length genomic SARS-CoV-2 RNA was in vitro transcribed using mMESSAGE mMACHINE T7 Ultra Transcription kit (Invitrogen) following the manufacturer's protocol. Four µg of DNA template was added to the reaction mixture, supplemented with GTP (7.5 µL per 50 µL reaction). Total RNA Kit I (Omega Bio-tek). Total RNA was extracted according to the manufacturer's protocol and eluted into RNase/DNase free H2O and used for library construction. Ribosomal RNA was removed from total RNA by Ribo-Zero depletion (Illumina). Indexed sequencing libraries were prepared using TruSeq RNA library preparation kit (Illumina), pooled and then sequenced using Illumina NextSeq system. The sequencing data were analyzed using the LoFreq pipeline to call the mutations in the entire virus genome 44 . In brief, Illumina sequencing data were filtered using fastp (https://github.com/OpenGene/fastp) trimming bases with a Phred quality score ≥Q30. High-quality reads were then aligned to the SARS-CoV-2 reference genome sequence (NC_045512.2) using BWA 45 . SAMtools was used to sort, index and remove duplicates from bam files, and local realignment and variant calling were achieved by LoFreq to generate the mutant report file 46 .

For HAstV1, the virus RNA was isolated from the virus stocks using Direct-zol RNA MicroPrep 

The Boon laboratory has received unrelated funding support in sponsored research agreements from AI Therapeutics, GreenLight Biosciences Inc., AbbVie Inc., and Nano targeting & Therapy Biopharma Inc.

Tables: Table 1 : Frequency of recovery of VA1 s2m mutants. A total of 9 attempts were made to rescue each VA1 s2m recombinant virus. Presence of infectious virus was detected using a focus forming assay. Astrovirus VA1

Human astrovirus 1

SARS-CoV-1 SARS-CoV-2 Reduced viral titers for VA1-s2m 9 , VA1-s2m 12, 33 , and VA1-s2m 12, 18, 24, 33 were detected at 96 hpi compared to WT (all P< 0.001). 

Molecular characterisation of the 3'-end of the astrovirus genome

A mobile genetic element with unknown function found in distantly related viruses

Distribution and Evolutionary History of the Mobile Genetic Element s2m in Coronaviruses

The structure of a rigorously conserved RNA element within the SARS virus genome

Screening of feral and wood pigeons for viruses harbouring a conserved mobile viral element: characterization of novel Astroviruses and Picornaviruses

A genetic element in the SARS-CoV-2 genome is shared with multiple insect species

Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome

Beyond the Gastrointestinal Tract: The Emerging and Diverse Tissue Tropisms of Astroviruses

Comparison of novel MLB-clade, VA-clade and classic human astroviruses highlights constrained evolution of the classic human astrovirus nonstructural genes

Propagation of astrovirus VA1, a neurotropic human astrovirus, in cell culture

Serial propagation of astrovirus in tissue culture with the aid of trypsin

Human astrovirus isolation and propagation in multiple cell lines

Construction of a genome-length cDNA clone for human astrovirus serotype 1 and synthesis of infectious RNA transcripts

A hidden gene in astroviruses encodes a viroporin

Coronavirus biology and replication: implications for SARS-CoV-2

Coronavirus Disease 2019-COVID-19

Mutation in position of 32 (G>U) of S2M differentiate human SARS-CoV2 from Bat Coronavirus. bioRxiv

De novo 3D models of SARS-CoV-2 RNA elements from consensus experimental secondary structures

Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms

Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy

Comparative Genomics Reveals Early Emergence and Biased Spatiotemporal Distribution of SARS-CoV-2

Analysis of Emerging Variants in Structured Regions of the SARS-CoV-2 Genome

No species-level losses of s2m suggests critical role in replication of SARS-related coronaviruses

Emerging viral mutants in Australia suggest RNA recombination event in the SARS-CoV-2 genome

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Immature and mature human astrovirus: structure, conformational changes, and similarities to hepatitis E virus

Role of individual caspases induced by astrovirus on the processing of its structural protein and its release from the cell through a non-lytic mechanism

Proteolytic processing of a serotype 8 human astrovirus ORF2 polyprotein

Proteolytic processing of the astrovirus capsid

Bat coronaviruses related to SARS-CoV-2 and infectious for human cells

The Short-and Long-Range RNA-RNA Interactome of SARS-CoV-2

Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p

Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2

Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis

Infection and Propagation of Astrovirus VA1 in Cell Culture

High Seropositivity Rate of Neutralizing Antibodies to Astrovirus VA1 in Human Populations. mSphere, e0048421

Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters

US Centers for Disease Control and Prevention. 2019-Novel Coronavirus (2019-nCoV) Real-time rRT-PCR Panel Primers and Probes

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv

IDseq-An open source cloud-based pipeline and analysis service for metagenomic pathogen detection and monitoring

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets

Fast and accurate long-read alignment with Burrows-Wheeler transform

Twelve years of SAMtools and BCFtools

Molecular Evolutionary Genetics Analysis across Computing Platforms

Jalview Version 2--a multiple sequence alignment editor and analysis workbench

The Vienna RNA websuite

Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure

A Novel SARS-CoV-2 Viral Sequence Bioinformatic Pipeline Has Found Genetic Evidence That the Viral 3' Untranslated Region (UTR) Is Evolving and Generating Increased Viral Diversity

Minimap2: pairwise alignment for nucleotide sequences

VA1-s2m

VA1-s2m

VA1-s2m

VA1-s2m

SARS-CoV-2-s2m 2-⁵